Nivolumab vs Propranolol
Nivolumab vs Propranolol: Overview
This comparison examines the pharmacological differences between Nivolumab and Propranolol.
Mechanism of Action
Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.
Propranolol: Non-selective beta-adrenergic receptor blocker.
Pharmacokinetics
Half-life: Nivolumab — 27 days; Propranolol — 3-6 hours.
Chemical Properties
Molecular Formula: Propranolol — C16H21NO2.
Molecular Weight: Propranolol — 259.3440 g/mol.
Type: Nivolumab — Antibody; Propranolol — Small molecule.